These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15661530)

  • 21. Delayed expression of apoptotic and cell-cycle control genes in carcinogen-exposed bladders of mice lacking p53.S389 phosphorylation.
    Bruins W; Jonker MJ; Bruning O; Pennings JL; Schaap MM; Hoogervorst EM; van Steeg H; Breit TM; de Vries A
    Carcinogenesis; 2007 Aug; 28(8):1814-23. PubMed ID: 17317680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Living with p53, dying of p53.
    Aylon Y; Oren M
    Cell; 2007 Aug; 130(4):597-600. PubMed ID: 17719538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted repression of bone morphogenetic protein 7, a novel target of the p53 family, triggers proliferative defect in p53-deficient breast cancer cells.
    Yan W; Chen X
    Cancer Res; 2007 Oct; 67(19):9117-24. PubMed ID: 17909016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in p53 research: an interdisciplinary perspective.
    Olivier M; Petitjean A; Marcel V; Pétré A; Mounawar M; Plymoth A; de Fromentel CC; Hainaut P
    Cancer Gene Ther; 2009 Jan; 16(1):1-12. PubMed ID: 18802452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gene therapy of malignant tumors].
    Schackert HK; Frost P
    Chirurg; 1993 Sep; 64(9):678-83. PubMed ID: 8222924
    [No Abstract]   [Full Text] [Related]  

  • 26. New insights into p53 based therapy.
    Lane DP; Brown CJ; Verma C; Cheok CF
    Discov Med; 2011 Aug; 12(63):107-17. PubMed ID: 21878188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 post-translational modification: deregulated in tumorigenesis.
    Dai C; Gu W
    Trends Mol Med; 2010 Nov; 16(11):528-36. PubMed ID: 20932800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of lipid metabolism by p53 - fighting two villains with one sword.
    Goldstein I; Rotter V
    Trends Endocrinol Metab; 2012 Nov; 23(11):567-75. PubMed ID: 22819212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Oncoprotein p53].
    Triviño López A; López Muñiz A
    Med Clin (Barc); 1994 Jun; 103(2):56-8. PubMed ID: 8051972
    [No Abstract]   [Full Text] [Related]  

  • 30. Heads and tails.Less-active tumor suppressor paradoxically promotes both longevity and cancer in humans.
    Beckman M
    Sci Aging Knowledge Environ; 2004 Nov; 2004(47):nf104. PubMed ID: 15564560
    [No Abstract]   [Full Text] [Related]  

  • 31. Ferroptosis in p53-dependent oncosuppression and organismal homeostasis.
    Galluzzi L; Bravo-San Pedro JM; Kroemer G
    Cell Death Differ; 2015 Aug; 22(8):1237-8. PubMed ID: 26143748
    [No Abstract]   [Full Text] [Related]  

  • 32. Simplify p53: just an activator.
    Engeland K
    Oncotarget; 2015 Jan; 6(1):3-4. PubMed ID: 25575818
    [No Abstract]   [Full Text] [Related]  

  • 33. Mechanisms of p53 Functional De-Regulation: Role of the IκB-α/p53 Complex.
    Carrà G; Crivellaro S; Taulli R; Guerrasio A; Saglio G; Morotti A
    Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916821
    [No Abstract]   [Full Text] [Related]  

  • 34. Gene regulation by the tumor suppressor p53 - The omics era.
    Fischer M
    Biochim Biophys Acta Rev Cancer; 2024 Jul; 1879(4):189111. PubMed ID: 38740351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutant p53 subverts PLK2 function in a novel, reinforced loop of corruption.
    Haupt S; Haupt Y
    Cell Cycle; 2012 Jan; 11(2):217-8. PubMed ID: 22214663
    [No Abstract]   [Full Text] [Related]  

  • 36. Caught in the cross fire: p53 in inflammation.
    Cooks T; Harris CC; Oren M
    Carcinogenesis; 2014 Aug; 35(8):1680-90. PubMed ID: 24942866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical translational potential of p53-related alterations as cancer biomarkers.
    Xiao M; Wang X; Chen W
    Histol Histopathol; 2015 Oct; 30(10):1171-83. PubMed ID: 26069201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The p53 tumor suppressor gene: structure, function and mechanism of action.
    Choisy-Rossi C; Reisdorf P; Yonish-Rouach E
    Results Probl Cell Differ; 1999; 23():145-72. PubMed ID: 9950033
    [No Abstract]   [Full Text] [Related]  

  • 39. Taking up the reins of power: metabolic functions of p53.
    Humpton T; Vousden KH
    J Mol Cell Biol; 2019 Jul; 11(7):610-614. PubMed ID: 31282931
    [No Abstract]   [Full Text] [Related]  

  • 40. SnapShot: p53 posttranslational modifications.
    Kruse JP; Gu W
    Cell; 2008 May; 133(5):930-30.e1. PubMed ID: 18510935
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.